Loading RIGL charts…
May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy
Loading RIGL comparable companies…
| RIGLRigel Pharmaceuticals Inc.(opens in a new tab) | $1.01B | $0.28B | +3.3% | 91.4% | 31.5% | 3.63× | 3.0× |
|---|---|---|---|---|---|---|---|
| HROWHarrow, Inc.(opens in a new tab) | $1.05B | $0.28B | +21.1% | 73.3% | −1.0% | 3.82× | — |
| PHATPhathom Pharmaceuticals, Inc.(opens in a new tab) | $0.49B | $0.27B | +86.8% | 80.7% | −9.3% | 1.77× | — |
| PTGXProtagonist Therapeutics, Inc(opens in a new tab) | $10.28B | $0.28B | +34.8% | — | 20.7% | 36.45× | 141.9× |
| SDGRSchrodinger, Inc.(opens in a new tab) | $2.06B | $0.26B | +8.9% | 56.9% | −59.2% | 7.94× | — |
| Medianpeers, excl. RIGL | $1.55B | $0.28B | +27.9% | 73.3% | −5.1% | 5.88× | 141.9× |